Rwy’n nodi bod y Grŵp Cynghori Gwyddonol ar Argyfyngau (SAGE) a’r Grŵp Cynghori ar Fygythiadau Feirysau Anadlol Newydd a Datblygol (NERVTAG) o’r farn bod amrywolion eraill yn debygol iawn o ddod i’r amlwg yn y dyfodol. Gallai'r rhain arwain at lefelau o niweidiau uniongyrchol sy’n fwy niweidiol nag sydd wedi’u gweld â’r amrywiolyn Omicron. Wrth inni lacio mesurau amddiffynnol yn ofalus, mae’r uchod yn cadarnhau fy nghyngor blaenorol bod angen inni sicrhau gallu profi digonol er mwyn cefnogi unigolion sy’n mynd yn sâl a chefnogi lleoliadau ac unigolion sy’n agored i niwed. Mae hyn hefyd er mwyn sicrhau bod gennym system effeithiol i gadw golwg ac ymateb o ran amrywolion sy’n newydd ac yn dod i’r amlwg.
I note the Scientific Advisory Group for Emergencies (SAGE) and New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) views that future variants are highly likely to appear and may lead to more significant levels of direct harm than have been seen with the Omicron variant. This supports my previous advice that, as we cautiously ease protective measures, we retain sufficient testing capacity to support individuals who become ill, to protect vulnerable individuals and settings, and to ensure we have an effective system for surveillance and response with regard to new and emerging variants.